Insider trade

CFO sold ~$106K of RGEN shares in the open market

Traded Jun 25, 2026 · Filed Jun 27, 2026

Why it stands out

The money chief of Repligen sold $106K of Repligen shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CFO$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$106,285

Shares × reported transaction price

Timing vs results

51 days after results of May 5, 2026, 27 days before results of Jul 22, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+3.3%	+1.4%	+1.9%
30 days	+3.1%	−1.6%	+4.7%
90 days	+41.7%	+3.3%	+38.4%

Past results only. Not a forecast.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025.

Scheduled in advance3mo ago

5mo ago

Compensation award — excluded from discretionary-purchase analysis.

5mo ago

Compensation award — excluded from discretionary-purchase analysis.